Every 8-K that Sabra Healthcare REIT, Inc. (SBRA) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow SBRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SBRA filings page.
Sabra Health Care REIT, Inc. reported Q2 2026 revenues of $235.9 million, up from $189.2 million a year earlier, but recorded a net loss of $25.2 million or $(0.10) per diluted share, driven largely by a $102.4 million provision for loan losses and other reserves. Cash-based metrics were stronger: Normalized AFFO was $103.5 million, or $0.40 per share, compared with $91.6 million, or $0.38 per share, in Q2 2025, supporting a quarterly dividend of $0.30 per share.
Same-property managed senior housing Cash NOI increased 13.7% year over year, and rent coverage in the triple-net portfolio remained solid, with skilled nursing at 2.49x, senior housing – leased at 1.52x, and behavioral health/specialty at 4.14x. Sabra continued to deploy capital, closing second-quarter senior housing and skilled nursing investments with total commitments of $274.1 million at an initial cash yield of 8.1%, bringing year-to-date investments to $599.0 million at a 7.5% estimated initial cash yield, and has been awarded another $100 million of investments at about 7.7%.
Liquidity was approximately $1.3 billion as of June 30, 2026, including $231.6 million of cash, and Net Debt to Adjusted EBITDA was 4.61x. The board declared a $0.30 quarterly dividend payable August 31, 2026, and Sabra reiterated its full-year 2026 guidance from its July 21, 2026 business update.
Sabra Health Care REIT outlined portfolio and balance-sheet moves and raised its 2026 earnings outlook. It plans to re-tenant all 26 properties leased to Avamere, shifting 22 to Cascadia Healthcare and four to an existing tenant. Upon closing, annualized cash rent from this portfolio is expected to be $53 million, nearly 30% above the $41 million received from Avamere, plus other initiatives adding over $9 million of run-rate cash NOI.
Sabra and Recovery Centers of America agreed to a $200 million cash repayment to settle a $300 million mortgage, reducing Net Debt to EBITDA from 5.0x to 4.8x and lowering behavioral health concentration of Annualized Cash NOI from 13% to 9%. Incorporating these actions and year-to-date performance, 2026 per-share guidance now ranges from $0.37–$0.39 of net income, $1.12–$1.14 of FFO, $1.53–$1.55 of Normalized FFO, $1.58–$1.60 of AFFO and $1.59–$1.61 of Normalized AFFO.
Sabra Health Care REIT, Inc. held its annual stockholder meeting on June 17, 2026. Stockholders elected seven directors to serve until the 2027 annual meeting and until their successors are elected and qualified.
They also ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026, with 226,576,585 votes for, 1,648,639 against and 173,917 abstentions. In addition, stockholders approved, on an advisory basis, the compensation of the company’s named executive officers, with 199,568,777 votes for, 7,867,562 against and 355,123 abstentions.
Sabra Health Care REIT, Inc. furnishes an investor presentation outlining recent investment activity, portfolio metrics, sustainability initiatives and capital structure. Year-to-date, Sabra has closed on $277 million of managed senior housing and skilled nursing investments at an estimated initial cash yield of 7.9%, and describes a pipeline of nearly $410 million in awarded investments at a 6.8% estimated initial yield. The company reports consolidated enterprise value of $7.8 billion as of March 31, 2026, supported by ample liquidity of about $1.2 billion and availability of $353.4 million under its at-the-market equity program. Key credit metrics include Net Debt to Adjusted EBITDA of 5.04x, an interest coverage ratio of 4.59x, weighted average debt maturity of roughly four years, and a 3.92% weighted average effective interest rate on permanent debt. Sabra also highlights portfolio diversification, favorable demographic tailwinds, environmental initiatives, and workforce diversity data.
Sabra Health Care REIT reported solid first quarter 2026 results and reiterated its full-year guidance. Net income attributable to common shareholders was $40.9 million, or $0.16 per diluted share. Key REIT metrics were stronger, with FFO of $0.37 and AFFO and Normalized AFFO of $0.39 per diluted share.
Same property managed senior housing Cash NOI rose 14.4% year over year, reflecting improving operating performance. Sabra invested $102.0 million in the quarter and $206.1 million year to date in senior housing and skilled nursing assets at an estimated initial cash yield of about 8.0%, and has been awarded an additional $200 million of higher-yielding opportunities.
Liquidity remained robust at approximately $1.2 billion as of March 31, 2026, including $116.5 million of cash, sizeable revolver capacity, and forward equity proceeds, while Net Debt to Adjusted EBITDA stood at 5.04x. The board declared a quarterly dividend of $0.30 per common share.
Sabra Health Care REIT reported fourth quarter 2025 diluted net income of $0.11 per share, with FFO of $0.36 and Normalized AFFO of $0.38 per share. Total revenue was $211.9 million, up from $182.3 million a year earlier, driven largely by its senior housing managed portfolio.
Same property managed senior housing Cash NOI rose 12.6% year over year in the quarter and averaged 15.0% growth for 2025. Sabra invested roughly $450 million in 2025 property acquisitions at an estimated 7.5% average initial cash yield and closed another $27.0 million after year-end.
The company has been awarded about $240 million of primarily managed senior housing and some skilled nursing investments at an estimated 8.0% initial cash yield. As of December 31, 2025, Net Debt to Adjusted EBITDA was 5.00x and liquidity totaled about $1.2 billion. The board declared a $0.30 quarterly dividend and issued 2026 guidance for net income of $0.60–$0.64 and Normalized AFFO of $1.55–$1.59 per diluted share.
Sabra Health Care REIT (SBRA) furnished materials reporting results for the three months ended September 30, 2025. The company provided a press release (Ex. 99.1), a supplemental information package (Ex. 99.2), non-GAAP reconciliations (Ex. 99.3), and an investor presentation (Ex. 99.4). These Items 2.02 and 7.01 materials are furnished, not filed, and the reconciliations and supplemental data are also available on Sabra’s investor website.